Different striatal D2-like receptor function in an early stage after unilateral striatal lesion and medial forebrain bundle lesion in rats

Brain Research

Volumn 1317, Issue , 2010, Pages 227-235

  Sun, Wei ^a   Sugiyama, Kenji ^a   Fang, Xin ^a   Yamaguchi, Hiroshi ^a   Akamine, Soichi ^a   Magata, Yasuhiro ^a   Namba, Hiroki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

6 hydroxydopamine; Dopamine D2 like receptor; Dopamine transporter; Parkinson disease; Positron emission tomography; Rat model

Indexed keywords

2BETA CARBOMETHOXY 3BETA (4 FLUOROPHENYL)TROPANE C 11; BROMOCRIPTINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; METHAMPHETAMINE; OXIDOPAMINE; RACLOPRIDE C 11; TRACER; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; EXPERIMENTAL RAT; IMMUNOHISTOCHEMISTRY; MALE; MEDIAL FOREBRAIN BUNDLE; NEUROIMAGING; NEUROPATHOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOACTIVITY; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; INJURY; METABOLISM; MOTOR ACTIVITY; NERVE CELL; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; SCINTISCANNING; SPRAGUE DAWLEY RAT; SYNAPTOSOME; TIME;

ANIMALIA; RATTUS;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MEDIAL FOREBRAIN BUNDLE; MOTOR ACTIVITY; NEURONS; NEUROPSYCHOLOGICAL TESTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 75849136383     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.048     Document Type: Article

References (38)

1. Antonini A., Vontobel P., Psylla M., Gunther I., Maguire P.R., Missimer J., and Leenders K.L. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Arch. Neurol. 52 (1995) 1183-1190
2. 11C]raclopride. Mov. Disord. 12 (1997) 33-38
3. Betarbet R., Sherer T.B., Di Monte D.A., and Greenamyre J.T. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol. 12 (2002) 499-510
4. Borlongan C.V., and Sanberg P.R. Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J. Neurosci. 15 (1995) 5372-5378
5. 11C-raclopride and positron emission tomography. Ann. Neurol. 31 (1992) 184-192
6. Brooks D.J. PET studies on the function of dopamine in health and Parkinson's disease. Ann. N.Y. Acad. Sci. 991 (2003) 22-35
7. Corrodi H., Fuxe K., Hokfelt T., Lidbrink P., and Ungerstedt U. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J. Pharm. Pharmacol. 25 (1973) 409-412
8. Damier P., Hirsch E.C., Agid Y., and Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122 Pt 8 (1999) 1437-1448
9. 11C]raclopride PET study. Mov. Disord. 14 (1999) 1025-1030
10. Deumens R., Blokland A., and Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 175 (2002) 303-317
11. 2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism. Synapse 38 (2000) 105-113
12. Fang X., Sugiyama K., Akamine S., and Namba H. The stepping test and its learning process in different degrees of unilateral striatal lesions by 6-hydroxydopamine in rats. Neurosci. Res. 55 (2006) 403-409
13. Fang X., Sugiyama K., Akamine S., and Namba H. Improvements in motor behavioral tests during deep brain stimulation of the subthalamic nucleus in rats with different degrees of unilateral parkinsonism. Brain Res. 1120 (2006) 202-210
14. German D.C., Manaye K., Smith W.K., Woodward D.J., and Saper C.B. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann. Neurol. 26 (1989) 507-514
15. 3H]dopa in various regions of the brain. J. Neurochem. 13 (1966) 655-669
16. Halliday G.M., McRitchie D.A., Cartwright H., Pamphlett R., Hely M.A., and Morris J.G. Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. J. Clin. Neurosci. 3 (1996) 52-60
17. Harada N., Nishiyama S., Satoh K., Fukumoto D., Kakiuchi T., and Tsukada H. Age-related changes in the striatal dopaminergic system in the living brain: a multiparametric PET study in conscious monkeys. Synapse 45 (2002) 38-45
18. Hefti F., Melamed E., and Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res. 195 (1980) 123-137
19. 3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats. Brain Res. 211 (1981) 285-292
20. Henry B., Crossman A.R., and Brotchie J.M. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Exp. Neurol. 151 (1998) 334-342
21. Hirsch E., Graybiel A.M., and Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334 (1988) 345-348
22. Hokfelt T., and Ungerstedt U. Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system. Brain Res. 60 (1973) 269-297
23. Inaji M., Okauchi T., Ando K., Maeda J., Nagai Y., Yoshizaki T., Okano H., Nariai T., Ohno K., Obayashi S., Higuchi M., and Suhara T. Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats. Brain Res. 1064 (2005) 136-145
24. 11C]N-methylspiperone. J. Nucl. Med. 41 (2000) 65-70
25. Kaufman M.J., and Madras B.K. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum. Synapse 9 (1991) 43-49
26. Kirik D., Rosenblad C., and Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152 (1998) 259-277
27. Leenders K.L., Aquilonius S.M., Bergstrom K., Bjurling P., Crossman A.R., Eckernas S.A., Gee A.G., Hartvig P., Lundqvist H., Langstrom B., et al. Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers. Brain Res. 445 (1988) 61-67
28. 2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET. Eur. J. Nucl. Med. Mol. Imaging 30 (2003) 390-395
29. Nishino H., Hida H., Takei N., Kumazaki M., Nakajima K., and Baba H. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum. Exp. Neurol. 164 (2000) 209-214
30. Paxinos G., and Watson C. The rat Brain in Stereotaxic Coordinates (1986)
31. Pellegrino D., Cicchetti F., Wang X., Zhu A., Yu M., Saint-Pierre M., and Brownell A.L. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. J. Nucl. Med. 48 (2007) 1147-1153
32. 2 receptors in vascular parkinsonism: a report of four cases. J. Neural. Transm. 112 (2005) 1355-1361
33. Przedborski S. Pathogenesis of nigral cell death in Parkinson's disease. Parkinsonism Relat. Disord. 11 Suppl 1 (2005) S3-7
34. Silverman P.B. On-off effects of dopamine receptor agonists in the hemi-parkinsonian rat. Eur. J. Pharmacol. 242 (1993) 31-36
35. Sotelo C., Javoy F., Agid Y., and Glowinski J. Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study. Brain Res. 58 (1973) 269-290
36. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. Suppl. 367 (1971) 49-68
37. Wilson J.M., Levey A.I., Rajput A., Ang L., Guttman M., Shannak K., Niznik H.B., Hornykiewicz O., Pifl C., and Kish S.J. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 47 (1996) 718-726
38. Yuan H., Sarre S., Ebinger G., and Michotte Y. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J. Neurosci. Methods 144 (2005) 35-45